Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

749
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
749
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

516
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
516

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cannabinoids in Alzheimer's disease: animal-human evidence and clinical pharmacology challenges.

Frontiers in behavioral neuroscience·2026
Same author

Antiulcer Activity of Herbal Medicines: A Review of Current Research.

Recent advances in anti-infective drug discovery·2026
Same author

Development and Validation of an Indian Nutrition and Food Literacy Tool (INFOLIT) for adolescents.

Frontiers in nutrition·2025
Same author

Multimodal Nanobiophysical Profiling of Melanoma-Derived Small Extracellular Vesicles Reveals Glycan Signatures Associated with Tumor Progression.

Nanotechnology, science and applications·2025
Same author

A Signature of Senescence Based on An Analysis of Selected Markers in Primary Vascular Smooth Muscle Cells Cultured In Vitro and Derived from Atherosclerotic Plaque.

Aging and disease·2025
Same author

Anillin Recedes in p53-Dependent Senescence of Tumor Cells and Reappears in Cells Escaping from Senescence.

Aging and disease·2025

Related Experiment Video

Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K

Biomarkers.

Simran Yadav1, Karolina Staniak1, Aida Muntsant Soria2

  • 1Laboratory of Preclinical Testing of Higher Standard, Nencki Institute of Experimental Biology of Polish Academy of Sciences, Warsaw, Poland.

Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|December 26, 2025
PubMed
Summary

Alzheimer

More Related Videos

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

702

Related Experiment Videos

Last Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K
Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

702

Area of Science:

  • Neuroscience
  • Genetics
  • Biochemistry

Background:

  • Circulating microRNAs (miRNAs) show promise as minimally invasive Alzheimer's disease (AD) biomarkers.
  • Previous research identified potential plasma miRNA biomarkers in humans.
  • Systematic validation in AD animal models was lacking.

Purpose of the Study:

  • To validate selected plasma miRNA candidates in a triple-transgenic (3xTg-AD) mouse model of Alzheimer's disease.
  • To compare miRNA levels in 3xTg-AD mice with non-transgenic (NTg) controls.
  • To assess the utility of miRNAs as biomarkers for AD pathogenesis.

Main Methods:

  • Plasma miRNA levels were measured using real-time quantitative PCR (RT-qPCR).
  • The study analyzed 16-20-month-old NTg and 3xTg-AD mice (n=17 per group).
  • Endogenous miR-192-5p was used as a normalizer, and spike-in miR-39-3p as an exogenous control.

Main Results:

  • Significant differences in plasma miRNA levels were observed between 3xTg-AD and NTg mice.
  • The observed miRNA alterations in the mouse model mirrored those found in human AD samples.
  • miR-192-5p was identified as a stable endogenous normalizer.

Conclusions:

  • The 3xTg-AD mouse model displays a plasma miRNA profile consistent with the human AD molecular signature.
  • These findings support the potential of miRNAs as reliable Alzheimer's disease biomarkers.
  • The 3xTg-AD model serves as a valuable platform for investigating miRNA roles in AD pathogenesis.